Access to results of clinical trials exploring the impact of therapies aimed at reducing hepatic accumulation of Z-AAT in patients with severe liver disease due to AATD are available online from the publicly available database, https://clinicaltrials.gov/ (accessed on 6 February 2022). The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.